SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 28th, 2017 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2017 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT this (“Agreement”), dated as of February 24, 2017, by and among Lixte Biotechnology Holdings, Inc., a Delaware corporation (the “Company”), and Lalit Bahl (“Purchaser”).